Protection provided by a recombinant ALVAC(®)-WNV vaccine expressing the prM/E genes of a lineage 1 strain of WNV against a virulent challenge with a lineage 2 strain.

Autor:in

Minke, J M; Siger, L; Cupillard, L; Powers, B; Bakonyi, T; Boyum, S; Nowotny, N; Bowen, R;

Schlagwörter

Animals; Antibodies, Viral/immunology; Cross Protection; Female; Horse Diseases/immunology; Horse Diseases/prevention & control*; Horse Diseases/virology; Horses; Male; Treatment Outcome; Vaccination/veterinary; Vaccines, Synthetic/administration & dosage*; Vaccines, Synthetic/genetics; Vaccines, Synthetic/immunology; Viral Envelope Proteins/genetics; Viral Envelope Proteins/immunology; Viral Envelope Proteins/metabolism; Viral Vaccines/administration & dosage*; Viral Vaccines/genetics; Viral Vaccines/immunology; West Nile Fever/immunology; West Nile Fever/prevention & control*; West Nile Fever/veterinary; West Nile Fever/virology; West Nile Virus Vaccines/administration & dosage*; West Nile Virus Vaccines/genetics; West Nile Virus Vaccines/immunology; West Nile virus/classification; West Nile virus/genetics; West Nile virus/immunology; West Nile virus/pathogenicity*;

ISSN/eISSN

0264-410X -

WoS ID

WOS:000292471700010